Herman Barkema is a Professor in Epidemiology of Infectious Diseases at the Faculty of Veterinary Medicine, University of Calgary, with a joint appointment in the Department of Community Health Sciences, Cumming School of Medicine. His research focuses on preventing infectious diseases in cattle herds (e.g., mastitis, Johne’s disease) and antimicrobial resistance, integrating animal and public health perspectives under the One Health framework. He founded the Department of Production Animal Health and leads the AMR – One Health Consortium and CAN-AMR-Net. DVM, Veterinary Medicine, Utrecht University (1988) PhD, Veterinary Science, Utrecht University (1998) His work spans clinical veterinary epidemiology, antimicrobial resistance mechanisms, and zoonotic disease control. He has over 425 publications and collaborates globally, including as a Foreign Expert at China Agricultural University. Recent research trends highlight his focus on multi-omics approaches, ceRNA networks, and antimicrobial stewardship in dairy systems, with significant contributions to Johne’s disease diagnostics and mastitis prevention. Roger Morris ISVEE Award (2024) Plowright Prize (2022) Killam Annual Professorship (2019) Multiple Journal of Dairy Science Most Cited Awards (2011–2024) Fellow, Canadian Academy of Health Sciences (2014) Dr. Barkema supervises graduate students and postdoctoral fellows, emphasizing interdisciplinary mentorship. He co-developed the Veterinary DialogueTrainer for clinical communication training and participates in public engagement initiatives like Breakfast on the Farm. He leads the AMR – One Health Consortium and CAN-AMR-Net, integrating stakeholders across Canada and internationally. His affiliations include the Snyder Institute for Chronic Diseases and strategic initiatives on Infectious Diseases and One Health (2015–2025).
Didier Trono is a Full Professor at École Polytechnique Fédérale de Lausanne (EPFL), where he leads the Laboratory of Virology and Genetics (LVG) within the School of Life Sciences. Formerly, from 2004 to 2012, he served as the founding dean of EPFL's Faculty of Life Sciences, orchestrating its development and growth during this formative period. Trono received his medical education at the University of Geneva, followed by clinical training in pathology, internal medicine, and infectious diseases in Geneva and at Massachusetts General Hospital in Boston. His scientific career began at the Whitehead Institute of MIT, and in 1990 he was recruited by the Salk Institute of San Diego to launch an AIDS research center. After seven years in the United States, he returned to Europe and eventually joined EPFL. Dr. Trono's research has evolved significantly over his career. Initially focusing on virus-host interactions, he studied pathogens like HIV and Hepatitis B virus, creating HIV-derived genetic transfer tools that are now successfully used in gene therapy. For approximately the last fifteen years, his research has centered on epigenetics, particularly exploring the impact of retroelements and their control mechanisms on development and physiology of higher organisms, including humans. His laboratory investigates how transposable elements and KRAB zinc finger proteins regulate gene expression, with important implications for understanding cancer biology and developing new diagnostic and therapeutic approaches. Analysis of his recent publications (2022-2024) reveals a strong focus on transposable elements, KRAB zinc finger proteins, and their roles in gene regulation and cancer. His work combines molecular biology, genomics, and bioinformatics approaches to understand how these ancient viral remnants have been co-opted by the host genome to regulate development and cellular functions. The research spans basic molecular mechanisms to potential clinical applications in cancer diagnosis and therapy, with some recent work also addressing SARS-CoV-2 and immune responses. Throughout his career, Professor Trono has mentored numerous PhD students, including Bojkowska Karolina, Brandão Sanches Vong Martins Filipe Amândio, Bulliard Yannick, Coluccio Andrea, Corsinotti Andrea, Coudray Alexandre, De Tribolet-Hardy Jonas Caspar, and Dorschel Iris Arianna. His laboratory has received significant funding to support research at the intersection of virology, genetics, and epigenetics, contributing to EPFL's reputation as a leading institution in life sciences research. The Trono Laboratory continues to be at the forefront of research on retroelements and their regulatory mechanisms, maintaining a vibrant research environment that bridges fundamental biological questions with potential medical applications, particularly in cancer research and precision medicine.
Harris H. Wang is an Associate Professor in the Department of Systems Biology and Department of Pathology and Cell Biology at Columbia University's Vagelos College of Physicians and Surgeons, where he also serves as Interim Chair of Systems Biology. He is affiliated with the Center for Computational Biology and Bioinformatics (C2B2) and the Integrated Program in Cellular, Molecular and Biomedical Studies (CMBS). B.S., Physics and Mathematics, MIT Ph.D., Biophysics, Harvard University Dr. Wang's research lies at the intersection of systems and synthetic biology, focusing on developing foundational technologies for genome engineering, microbiome manipulation, and synthetic genomics. His lab pioneers methods such as MAGE, MAGIC, CAST, and CAMII to enable high-throughput genetic manipulation, in situ microbiome engineering, and AI-driven microbial culturomics. Key research themes include understanding microbial community dynamics, engineering cellular memory systems, designing biocontained genetic circuits, and applying synthetic biology to human health challenges in personalized medicine and infectious disease. His recent publications reveal a strong trend in spatial and functional metagenomics, CRISPR-based microbiome editing, and synthetic biology tools for data storage and genetic stability. The articles span high-impact journals like Nature , Science , and Nature Biotechnology , reflecting his leadership in developing scalable, programmable biological systems. Scientific Awards: NIH Director’s Early Independence Award Forbes 30 Under 30 in Science Sloan Research Fellowship NSF CAREER Award ONR Young Investigator Award Burroughs Wellcome Fund PATH Award Schaefer Scholar Blavatnik National Award Vilcek Prize PECASE Dr. Wang has advised numerous PhD and postdoctoral researchers, many of whom have gone on to independent scientific careers. His lab is supported by major grants from NIH, NSF, DARPA, DOE, and foundations including the Bill & Melinda Gates Foundation and CZ Biohub NY. He is actively involved in educational initiatives, including organizing Columbia’s iGEM team and the Cold Spring Harbor Laboratory Synthetic Biology course. The Wang Lab is based at the Columbia University Irving Medical Center and is part of national consortia such as the Engineering Biology Research Consortium (EBRC) and the Genome Project-Write (GP-Write) initiative. The lab develops and applies cutting-edge technologies in automation, machine learning, and synthetic biology to engineer microbiomes for applications in medicine, global health, and climate change.
Prof. Marcy Zenobi-Wong is a Full Professor at ETH Zurich's Department of Health Sciences and Technology, specializing in biofabrication and tissue engineering. Her research focuses on cartilage regeneration using advanced biomaterials, including nanofilm coatings and 3D printing techniques. She holds patents in tissue engineering and has pioneered methods like filamented light (FLight) biofabrication for creating anisotropic tissues. Her academic journey includes a B.Sc. from MIT (1985), M.Sc. and Ph.D. from Stanford (1987, 1990), followed by postdoctoral work at the University of Michigan. She leads the Biofabrication Group at ETH, developing therapies for joint repair and regenerative medicine. Courses taught include Biomedical Engineering and Materials and Mechanics in Medicine . Research highlights include engineered hydrogels for cartilage protection, CRISPR-driven gene editing in chondrocytes, and biohybrid neural interfaces. Her work bridges material science, cell biology, and clinical applications, with a focus on translational medicine. Collaborative projects involve creating elastic cartilage grafts for microtia reconstruction and volumetric printing of complex tissue constructs.
Scott D. Sagan is the Caroline S.G. Munro Professor of Political Science at Stanford University and a Senior Fellow at the Freeman Spogli Institute for International Studies. He serves as Co-Director of the Center for International Security and Cooperation (CISAC) and holds the position of Bass University Fellow in Undergraduate Education. Sagan also co-chairs the American Academy of Arts and Sciences' Committee on International Security Studies, demonstrating his significant influence in the field of international security. Sagan received his Ph.D. in Political Science from Harvard University in 1983 and his B.A. in Government from Oberlin College in 1977. Prior to joining Stanford, he taught at Harvard University and served as special assistant to the director of the Organization of the Joint Chiefs of Staff in the Pentagon, providing him with valuable practical experience in defense policy. Professor Sagan's research primarily focuses on nuclear weapons policy, international security, arms control, and nonproliferation. His work examines the organizational, political, and ethical dimensions of nuclear strategy, with particular attention to the risks of nuclear accidents, the effectiveness of nonproliferation policies, and public attitudes toward nuclear weapons use. He has pioneered important theoretical frameworks regarding the organizational causes of nuclear accidents and the normative constraints on nuclear weapons use. Sagan's publications reveal a consistent focus on nuclear deterrence theory, the organizational aspects of nuclear command and control, and the ethical dimensions of nuclear weapons policy. His work bridges theoretical analysis with practical policy implications, often challenging conventional wisdom about nuclear strategy and proliferation. Recent publications show increasing attention to public opinion on nuclear weapons use, the evolving nature of nuclear deterrence in the contemporary security environment, and the relationship between international law and nuclear strategy. Thérèse Delpech Memorial Award (2022) Susan Strange Award, International Studies Association (2017) William and Katherine Estes Award, National Academy of Sciences (2015) International Security Studies Section Distinguished Scholar Award (2013) Stanford's Dean's Award for Distinguished Teaching (1998-99) Stanford's Hoagland Prize for Undergraduate Teaching (1996) International Studies Association's Innovative Teaching Award (2008) Monterey Institute for International Studies' Nonproliferation Education Award (2009) Sagan has been instrumental in shaping the research agenda at CISAC, mentoring numerous students and junior scholars in the field of international security. His work has been supported by various research grants from foundations and government agencies focused on nuclear security issues. At Stanford, he has led numerous research initiatives examining nuclear weapons policy, arms control, and nonproliferation challenges. As Co-Director of CISAC, Sagan oversees one of the world's leading research centers on international security, nuclear policy, and arms control. The center brings together scholars, practitioners, and students to address pressing security challenges through interdisciplinary research, policy-relevant analysis, and educational programs. Under his leadership, CISAC has maintained its position as a premier institution for security studies research and policy engagement.
James B. Kaper is a Professor and Chair of the Department of Microbiology & Immunology at the University of Maryland School of Medicine. He serves as Vice Dean for Academic Affairs and previously held leadership roles as Senior Associate Dean (2014–2019) and Chair (2007–present). His research focuses on the molecular pathogenesis of diarrheagenic Escherichia coli and Vibrio cholerae , including vaccine development and bacterial-host interactions. Education: BS (1973) and PhD (1979) in Microbiology from University of Maryland; Postdoc in Molecular Pathogenesis at University of Washington (1979–1981) Dr. Kaper’s work has led to the creation of live attenuated cholera vaccines, including CVD 103-HgR, the first licensed recombinant bacterial vaccine. His lab investigates bacterial genetics, intestinal colonization, and immune system activation, particularly TLR5 response to V. cholerae flagellin. He has authored 303 peer-reviewed articles and 68 book chapters. His research has been funded continuously by NIAID since 1982. Key publications include foundational work on V. cholerae vaccines (1984), genomic structure (1998), and quorum sensing in EHEC/EPEC (1999). His lab’s recent studies focus on phosphotyrosine proteomics (2013) and pathogenicity island regulation (2007). Scientific awards: Fellow, American Academy of Microbiology (1994); NIH Merit Award (2004); ASM DC White Award (2019) Editorial roles: Editor-in-Chief, EcoSal (2006–present); Associate Editor, International Journal of Medical Microbiology (2000–present) As an academic leader, Dr. Kaper has mentored over 60 graduate students and postdoctoral fellows. He holds multiple patents for cholera vaccines and E. coli diagnostics, including U.S. Patents 4,935,364; 5,399,494; and 6,204,004. His lab at UMSOM combines basic science with translational applications for enteric disease prevention.
Alexis Battle is an Associate Professor at Johns Hopkins University with appointments in Biomedical Engineering , Computer Science , and Genetic Medicine (secondary). She directs the Malone Center for Engineering in Healthcare and serves as Deputy Director of the Data Science and AI Institute . Educated at Stanford University (PhD in Computer Science, 2013), Battle transitioned to academia after leadership roles at Google. Research Focus: Battle’s work bridges genomics and machine learning , emphasizing the impact of genetic variation on human health. Her lab develops tools like Watershed to predict functional effects of rare variants, aiming to enhance rare disease diagnosis. Key themes include non-coding DNA analysis , personalized genomics , and systems biology , with applications in cardiovascular disease and neurodegenerative disorders . Publications & Awards: Over 60 peer-reviewed articles in journals like Nature , Science , and Genome Biology , with recent emphasis on single-cell transcriptomics , multiomics integration , and telomere biology . Recipient of the President’s Frontier Award (2022), Microsoft Investigator Fellowship (2019), and Searle Scholar (2016). Scientific Awards: 2022 President’s Frontier Award 2019 Microsoft Investigator Fellowship 2019 Johns Hopkins Discovery Award 2017 Johns Hopkins Catalyst Award 2016 Searle Scholar Advising & Funding: Mentors 11 PhD students, 3 undergraduates, and postdoctoral fellows. Her research is funded by NIH, Searle Scholars, and institutional grants. The Battle Lab collaborates on projects like the GTEx Consortium , focusing on gene regulation and clinical genomics .
Martin T. Wells is the Charles A. Alexander Professor of Statistical Sciences at Cornell University, with joint appointments in the Department of Statistical Science, Department of Biological Statistics and Computational Biology, Department of Social Statistics, and as Professor of Clinical Epidemiology and Health Services Research at Weill Medical School. He serves as Editor-in-Chief of the ASA-SIAM Book Series and Co-Editor of the Journal of Empirical Legal Studies. Cornell University, Ithaca, NY Weill Cornell Medical College Research Interests span applied and theoretical statistics, Bayesian methods, biostatistics, clinical epidemiology, and computational biology. His work bridges disciplines like finance, legal studies, and health services research. Article Trends highlight advancements in Bayesian modeling, quantum cognition machine learning, tensor analysis, and misclassification correction, with applications in genomics, finance, and public health. Fellow of the American Statistical Association Fellow of the Royal Statistical Society Contributions include developing statistical software (e.g., rTensor), methodological innovations in clinical trials, and empirical legal studies on civil rights and the death penalty.
Roberto Navigli is a Full Professor in the Department of Computer, Control and Management Engineering at Sapienza University of Rome, where he leads the Sapienza NLP Group. He has held academic positions at Sapienza since 2007, progressing from Researcher to Associate Professor, and now Full Professor. Navigli is internationally recognized for his groundbreaking work in multilingual natural language processing and computational semantics. His research spans multiple areas within Natural Language Processing, with a particular focus on multilinguality , lexical semantics (Word Sense Disambiguation and induction), sentence-level semantics (Semantic Role Labeling and Semantic Parsing), and Large Language Models . As the leader of the Minerva LLM project, he pioneered the development of the first pretrained LLM in Italian. His creation of BabelNet, the largest multilingual encyclopedic computational dictionary covering 271 languages and about 14 million concepts, represents a landmark achievement in computational linguistics. Professor Navigli's recent publications demonstrate a strong focus on advancing multilingual capabilities of language models, addressing challenges in semantic understanding across languages, and developing robust evaluation frameworks. His work on Italian LLM optimization, lexical ambiguity in machine translation, and cross-lingual safety gaps reflects his commitment to building more accurate and reliable language technologies that work effectively across diverse linguistic contexts. AAAI Fellow (2025) EurAI Fellow (2024) ELLIS Fellow (2024) ACL Fellow (2023) Outstanding Paper Awards at ACL 2024, ACL 2023, and NAACL 2021 Best Resource Paper Award at ACL 2022 Prominent Paper Awards from the Artificial Intelligence Journal (2023, 2017) META Prize 2015 for BabelNet Professor Navigli has successfully secured substantial research funding, including two prestigious ERC Grants (MultiJEDI ERC Starting Grant 2010-2016 and MOUSSE ERC Consolidator Grant 2017-2023, totaling around 3 million euros), PI of PRIN 2017 and PRIN 2020 projects (overall 1.4 million euros), and a Google Focused Research Award (around 300k$). He has mentored over 30 PhD students, many of whom have gone on to successful careers in academia and industry. His leadership extends to major international conferences, serving as General Chair of ACL 2025 and Program Co-Chair of ACL-IJCNLP 2021. As the director of the Sapienza NLP Group and co-leader of the Transversal Project on Large Language/Multimodal Models in the FAIR (Future Artificial Intelligence Research) project, Professor Navigli oversees a vibrant research ecosystem focused on advancing the state-of-the-art in natural language understanding across languages. His spinoff company, Babelscape, translates academic research into practical applications for industry.
Dr. Giulia Biancon is an Assistant Professor Adjunct in the Department of Medical Oncology and Hematology at Yale School of Medicine. She holds a PhD from the University of Milan (2019) and is a member of the Halene Lab, focusing on RNA biology and hematologic malignancies. Her research combines high-throughput methodologies to study RNA mechanisms in diseases like myeloid leukemias and splicing factor mutations. Education: PhD in Molecular Biology from the University of Milan (2019). Research Interests: RNA splicing, stress granules in cancer, epitranscriptomics, clonal hematopoiesis, and the interplay between genetic mutations and cellular pathways in blood cancers. Awards: 2024 Eclipse Award, 2022 ASH Abstract Achievement Award, and 2022 RNA Society Best Poster Award. Her work has been published in journals like Cell Reports , Blood , and Molecular Cell . Labs/Teams: Principal member of the Halene Lab and coordinator at the Yale Center for RNA Science and Medicine. Collaborates with institutions like the SeroNet network for immunology studies.
Ryo Morimoto is a Research Fellow and Group Leader at the Department of Molecular Biology, Umeå University, affiliated with Molecular Infection Medicine Sweden (MIMS). He leads studies on the evolutionary foundations of adaptive immunity and host genome editing mechanisms. MD (2011) and PhD (2017) from University of Tokyo Postdoctoral work at Max Planck Institute for Immunobiology & Epigenetics (2017-2024) Project Leader (2022) and Group Leader (2024) at MIMS His research explores antigen receptor diversification in jawless vertebrates, evolutionary emergence of lymphopoietic systems, and self-tolerance mechanisms. Using non-conventional models, his lab integrates in vitro biochemistry, single-cell omics, and computational genomics to address genome integrity challenges in adaptive immunity. The lab's recent publications highlight evolutionary insights into immune system development and its implications for human immunity. Research focuses on conserved enzyme families mediating genome editing and their biotechnological applications. Ryo Morimoto's team emphasizes multicultural collaboration, interdisciplinary training, and skill development for early-career scientists. The lab maintains partnerships with Umeå Centre for Microbial Research (UCMR) and employs in vivo techniques alongside molecular and computational approaches.
Professor Mark Coles serves as Professor of Immunology and Lead for Industrial Strategy and Entrepreneurship at the Kennedy Institute of Rheumatology, University of Oxford, holding concurrent roles as Kennedy Trust Senior Research Fellow, Official Fellow at Reuben College, and Affiliate Faculty at the Wolfson Centre of Mathematical Biology. His interdisciplinary work bridges immunology, computational modeling, and translational research to accelerate therapies for immune-mediated inflammatory diseases. His academic journey began with a BSc in Microbiology from Cornell University (1992), followed by a PhD in Molecular and Cell Biology at UC Berkeley under David Raulet, and postdoctoral training with Dimitris Kioussis at the National Institute of Medical Research. At the University of York (2006-2017), he pioneered stromal immunology research and co-founded the York Computational Immunology Laboratory. Coles' research centers on stromal and systems immunology, with core expertise in stromal cell biology, inflammatory disease mechanisms, and mathematical modeling of immune responses. He champions 3Rs-based approaches (Replacement, Reduction, Refinement) to reduce animal testing through in silico models, integrating spatial single-cell biology with multi-scale computational frameworks to dissect immune function in human tissues. His 2025 publications reveal a cohesive research trajectory applying interdisciplinary methods across diverse disease contexts—from cardiac fibrosis and vaccine responses to arthritis pathogenesis and CAR-T cell therapy—unified by focus on stromal-immune crosstalk and quantitative modeling to identify therapeutic targets. Key honors include: Fellow of the Royal Society of Biology Kennedy Trust Senior Research Fellow As former Director of Graduate Studies (2017-2024) at the Kennedy Institute, Coles mentored numerous graduate students while co-leading major initiatives including the Arthritis Therapy Acceleration Program and Human Cell Atlas medicalization. His entrepreneurial impact spans three co-founded ventures: Simomics Ltd (in silico disease modeling), Lightox Ltd (phototherapy for oral cancer), and Mestag Therapeutics (fibroblast-targeted therapies for cancer/inflammation). He directs the Laboratory of Stromal and Systems Immunology and Oxford Mathematical Immunology Group, fostering collaborations with Christopher Buckley, Calliope Dendrou, and Eamonn Gaffney to develop Quantitative Systems Pharmacology models that translate mechanistic insights into patient therapies.
Elizabeth Bernstein is a Professor of Women's, Gender & Sexuality Studies and Professor of Sociology at Barnard College, Columbia University, where she has been a faculty member since September 2002. Her work bridges sociological theory with feminist analysis, focusing on the intersections of gender, sexuality, and political economy. Bernstein directs significant research initiatives including the Gender Justice and Neoliberal Transformations Working Group, a transnational collaboration among thirteen scholars examining gender justice in contemporary global contexts. She is currently developing a new book project titled "Imagining Immunity: Precarious Bodies and the Governance of Gendered Dis-ease," which explores immunological metaphors in understanding bodily risk and suffering. B.A., University of California, Berkeley M.A., University of California, Berkeley Ph.D., University of California, Berkeley Professor Bernstein's research focuses on the political economy of the body, gender, and sexuality, with particular attention to sexual commerce, sex trafficking, and neoliberal governance. Her work employs ethnographic methods to examine how intimate relations become sites of economic exchange and political regulation. She investigates how concepts of authenticity, freedom, and rights are mobilized in debates about sexual commerce and trafficking. Bernstein's scholarship critically engages with feminist theory, carceral politics, and transnational governance frameworks, challenging conventional approaches to sex work and trafficking that often reinforce punitive systems rather than advancing gender justice. Analysis of Bernstein's scholarly output reveals a consistent trajectory examining the intersections of gender, sexuality, and political economy within neoliberal frameworks. Her work demonstrates increasing attention to transnational governance mechanisms and their impact on intimate relations and bodily autonomy. A notable trend is her critical examination of how anti-trafficking campaigns often employ carceral logic that undermines feminist goals of gender justice. Her scholarship consistently challenges binary frameworks that position sex work solely as exploitation or liberation, instead analyzing the complex economic, political, and social dynamics that shape sexual commerce globally. Bernstein's research has received significant recognition through prestigious awards including: Distinguished Book Award, American Sociological Association, Sociology of Sexualities Section (2020) for "Brokered Subjects" Honorable Mention, Society for the Study of Social Problems Global Division Book Award (2019) Norbert Elias Prize, Norbert Elias Foundation (2009) Distinguished Book Award, American Sociological Association, Sex and Gender Section (2009) Her work has also been supported by major funding organizations including the Institute for Advanced Study, National Science Foundation, Social Science Research Council, AAUW, and Mellon Foundation. As a principal investigator along with Janet Jakobsen for the Gender Justice and Neoliberal Transformations Working Group, Bernstein leads a significant collaborative research initiative sponsored by the Barnard Center for Research on Women. Her grant portfolio demonstrates sustained support from major research institutions, reflecting the significance of her work in gender studies and sociology. While specific student advisees aren't listed in the available materials, her role as a full professor at Barnard College indicates extensive mentorship of undergraduate and likely graduate students in Women's, Gender & Sexuality Studies and Sociology. Bernstein co-leads the Gender Justice and Neoliberal Transformations Working Group, a collaboration among thirteen scholars working transnationally on questions of gender justice. This initiative represents a significant research collective examining how neoliberal policies reshape gender relations globally. Her work with the Barnard Center for Research on Women provides institutional support for this transnational feminist research network, facilitating scholarly exchange and collaborative publication projects that advance critical perspectives on gender, sexuality, and political economy.
Hyun (Michel) Koo is a Professor at the University of Pennsylvania School of Dental Medicine , with affiliations in the Department of Orthodontics , Division of Community Oral Health , and Division of Pediatric Dentistry . As Co-Founder and Co-Director of the Center for Innovation & Precision Dentistry (CiPD) , he leads interdisciplinary efforts merging bioengineering, nanotechnology, and oral health research. Education : DDS and PhD Research Focus : Biofilms, bacterial-fungal interactions, and nanotechnology for oral disease prevention Leadership : Co-Director of CiPD; key roles in training programs like NIDCR-sponsored R90 and T90/R90 Dr. Koo’s research explores biofilm mechanisms in oral infectious diseases, particularly childhood caries, through engineering methods and microrobotics . His team developed micron-scale robots for automated biofilm eradication and FDA-approved nanoparticles for caries prevention. Collaborations with Penn Engineering, including Dr. Daeyeon Lee and Dr. Kacy Cullen, emphasize translational approaches. The 15 most recent publications highlight his work in nanorobotics , interkingdom biofilms , and precision diagnostics . Articles span 2025–2024 and address topics like adaptive micromotors , biofilm matrix degradation , and single-cell microbial interactions . These emphasize his focus on targeted therapies and biofilm microenvironment engineering . Key Awards : Elected Fellow, American Association for the Advancement of Science (AAAS) IADR Distinguished Scientist Award for innovative dental research Dr. Koo trains next-generation researchers through the CiPD NIDCR T90/R90 Postdoctoral Training Program , mentoring fellows like Smruti Nair (ACE2 Chewing Gum development) and Zhi Ren (K99 awardee). His work intersects with Penn Health-Tech, CT3N , and Penn Institute for Biomedical Informatics , fostering transdisciplinary innovation.
Paul O'Toole is a Professor of Microbial Genomics and Principal Investigator at the APC Microbiome Ireland, University College Cork. His research focuses on the gut microbiome's role in health, aging, and disease, particularly in the context of diet and probiotics. He leads projects like the ELDERMET study on elderly nutrition and the NU-AGE project exploring Mediterranean diets' anti-aging effects. He holds a BA (Mod.) from Trinity College Dublin and a PhD from Lund University, with postdoctoral training in Canada and New Zealand. Key grants include studies on dairy-derived microbiota, probiotic strain improvement, and microbiome analysis in aging populations. He has published extensively on Lactobacillus genomics, gut-brain interactions, and microbiome-driven health outcomes. His work bridges fundamental microbiology with clinical applications, emphasizing translational research. Scientific highlights include discovering microbiome links to cognitive decline, demonstrating dietary modulation of gut microbes to combat obesity, and identifying keystone species in healthy aging. He advocates for sustainability in conservation and food systems, reflecting his interdisciplinary approach to global health challenges.
